Nama's AI scorecard currently rates Chemours Sell (3.9 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.

What is CC's P/E ratio?

Chemours trades at a trailing price-to-earnings ratio of 17.5.

When does CC report earnings?

Chemours's next scheduled report is on Feb 18, 2027. Analysts expect EPS of $0.26.

What is the CC price target?

The median analyst price target from 10 analysts is $16.00, with a range of $14.00 – $18.00.

Is CC Shariah compliant?

Nama's AAOIFI-style screen reads Chemours as Not Shariah Compliant. At least one of the three ratios or the industry test failed.

Does CC pay a dividend?

Yes — Chemours's dividend yield is 2.8%.

Nama Insights

Chemours (CC)

Basic Materials · Specialty Chemicals · NYSE

Chemours (CC) is a Basic Materials company in the Specialty Chemicals industry. It has a market capitalization of $1.92B, a trailing price-to-earnings ratio of 17.5 and a free-cash-flow yield of 2.7%. Over the most recent reported fiscal year, revenue grew 0.5%. Nama's AI scorecard rates it Sell, 3.9 out of 10. On 12-month momentum it ranks in the middle band of its market.

AI scorecard

Sell · 3.9/10

Negative, at the mild end of Sell. As of Nov 7, 2026.

Momentum

Middle · +19.1% over 12 months ex. last

Middle fifth of its market on the past year's move.

Shariah screen

Not Shariah Compliant

At least one of the three ratios or the industry test failed.

Off its high

-71.6%

How far the last close sits under the highest price of the past five years.

Market cap	$1.92B
Trailing P/E	17.5
Price / book	—
Price / sales	0.3
FCF yield	2.7%
Dividend yield	2.8%
Gross margin	15.3%
Operating margin	-1.4%
Net margin	-5.2%
Revenue growth (YoY)	+0.5%
Revenue growth (3-yr annual)	-5.3%
EPS growth (YoY)	-20.7%
FCF/share growth (YoY)	—
Beta	1.4
Exchange	NYSE
Sector	Basic Materials
Industry	Specialty Chemicals

CC earnings

Next report: Feb 18, 2027 (Q4 2026, EPS estimate $0.26). Beat the EPS estimate in 2 of 4 recent quarters.

Quarter	Reported	EPS	Estimate	Surprise	Revenue
Q3 2026	Nov 2, 2026	$0.21	$0.26	-19.2%	—
Q2 2026	Aug 4, 2026	$0.42	$0.42	+0.0%	$1.59B
Q1 2026	May 5, 2026	$0.05	-$0.04	+225.0%	$1.38B
Q4 2025	Feb 19, 2026	$0.05	$0.02	+150.0%	$1.33B

CC analyst price target

Median target $16.00 from 10 analysts, ranging $14.00 – $18.00.

Specialty Chemicals peers

Ticker	Company	Market cap	P/E
LIN	Linde	$236.54B	30.9
ECL	Ecolab	$84.33B	37.4
SHW	Sherwin-Williams	$83.13B	28.9
APD	Air Products and Chemicals	$67.88B	22.7
PPG	PPG Industries	$27.03B	15.7
IFF	International Flavors & Fragrances	$20.69B	22.3
LYB	LyondellBasell Industries	$19.63B	8.6
DD	DuPont de Nemours	$19.42B	20.9

Explore live CC data on Nama Insights →

Recent Congressional trades

Chemours trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Michael C. Burgess	House	Buy	$15,001 - $50,000	Sep 5, 2023
Tammy Duckworth	Senate	Sell	$1,001 - $15,000	—

CC FAQ

Is CC a buy?: Nama's AI scorecard currently rates Chemours Sell (3.9 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
What is CC's P/E ratio?: Chemours trades at a trailing price-to-earnings ratio of 17.5.
When does CC report earnings?: Chemours's next scheduled report is on Feb 18, 2027. Analysts expect EPS of $0.26.
What is the CC price target?: The median analyst price target from 10 analysts is $16.00, with a range of $14.00 – $18.00.
Is CC Shariah compliant?: Nama's AAOIFI-style screen reads Chemours as Not Shariah Compliant. At least one of the three ratios or the industry test failed.
Does CC pay a dividend?: Yes — Chemours's dividend yield is 2.8%.